Comparison 2. Aripiprazole versus typical antipsychotic drugs(medium / long term > 12 weeks).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Death	1	1294	Risk Ratio (M‐H, Random, 95% CI)	2.01 [0.23, 17.94]
2 Leaving study early	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
2.1 Discontinuation due to any reason	1	1294	Risk Ratio (M‐H, Random, 95% CI)	0.81 [0.75, 0.89]
2.2 Discontinuation due to adverse event including psychosis	1	1294	Risk Ratio (M‐H, Random, 95% CI)	0.78 [0.65, 0.93]
2.3 Discontinuation due to lack of efficacy	1	1294	Risk Ratio (M‐H, Random, 95% CI)	0.83 [0.57, 1.23]
2.4 Discontinuation due to marked deterioration	1	1294	Risk Ratio (M‐H, Random, 95% CI)	1.24 [0.93, 1.64]
2.5 Discontinuation due to non‐compliance with study protocol	1	1294	Risk Ratio (M‐H, Random, 95% CI)	0.44 [0.33, 0.59]